Dr. Sarah Yeo Awarded 2024 Casey Morris Innovation Grant
- TRACKER Biobank
- Dec 20, 2024
- 2 min read
Updated: Jan 21
We are thrilled to announce that Dr. Sarah Yeo, a dedicated respiratory specialist and graduate researcher, has been awarded the prestigious 2024 Casey Morris Innovation Grant from Lung Foundation Australia. This grant will support Dr. Yeo’s pioneering research aimed at improving outcomes for metastatic lung cancer patients receiving immunotherapy, a critical area in advancing lung cancer care.
Tackling Immunotherapy Resistance with Cutting-Edge Research
Dr. Yeo’s project addresses a significant challenge in cancer treatment: resistance. While immunotherapy has shown promise for treating lung cancer, many patients develop resistance, limiting its effectiveness. Using advanced multi-omics analysis and valuable samples from the TRACKER Biobank, Dr. Yeo’s research aims to identify genetic and cellular differences between patients who respond to immunotherapy and those who do not.
Her key research objectives include:
Identifying Key Differences: Uncovering genetic and cellular factors that distinguish responders from non-responders.
Predicting Resistance: Developing biomarkers that predict resistance risk, allowing for more targeted and effective treatments.
Driving Innovation: Exploring new approaches to enhance immunotherapy effectiveness and offer alternative treatments for those who do not respond.
Why This Research Matters
Lung cancer remains Australia’s leading cause of cancer-related deaths, with many cases diagnosed in advanced stages. While immunotherapy has brought new hope, resistance remains a significant barrier, leading to disease progression and decreased survival rates.
Dr. Yeo’s research has the potential to:
Guide Treatment Decisions: Identifying biomarkers that empower clinicians to make more informed treatment choices.
Improve Therapy Effectiveness: Finding ways to optimise immunotherapy for a broader range of patients.
Enhance Patient Lives: Offering insights that could prolong and improve the lives of lung cancer patients through more personalised treatment strategies.
A Collaborative Effort
Dr. Yeo’s work is made possible through collaboration with a multidisciplinary team of experts and the support of TRACKER’s advanced biobank resources.
We are incredibly proud of Dr. Sarah Yeo’s achievement and her dedication to advancing lung cancer research. Join us in celebrating her success and stay tuned for updates on her important research as it unfolds.
コメント